Cancer Family
Glandular Cell Neoplasm
CI-CAN-00000188Explore in graph →
Non-malignant2,825 active trials43 approved drugs426 evidence items
- NCIt
- C7132
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000188Explore in graph →
Clinical trials
10,211 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01930864 | Metformin Plus Irinotecan for Refractory Colorectal Cancer | unknown | Phase 2 | 41 | Barretos Cancer HospitalOTHER | 1 | Jun 22, 2017 | clinicaltrials |
| NCT03192618 | The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial. | unknown | Phase 3 | 290 | Sun Yat-sen UniversityOTHER | 1 | Jun 20, 2017 |
| clinicaltrials |
| NCT01393093 | Transcatheter Arterial Chemoembolization With KMG Microsphere Treating Advance-stage Hepatocellular Carinomas(TACE-KMG) | unknown | N/A | 2,840 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Jun 12, 2017 | clinicaltrials |
| NCT03178929 | Effect of SAMe Treatment on Recurrence After Radical Treatment of Primary Hepatic Carcinoma | unknown | N/A | 207 | Beijing Insight Science & Technology Co. Ltd.OTHER | 0 | Jun 7, 2017 | clinicaltrials |
| NCT03033186 | Everolimus TDM to Predict Long Term Toxicity(Foresight) | unknown | — | 40 | Maastricht University Medical CenterOTHER | 1 | May 31, 2017 | clinicaltrials |
| NCT03167385 | Phase 2 Trial of Apatinib Mesylate in Locally Advanced/Metastatic Differentiated Thyroid Carcinoma | unknown | Phase 2 | 20 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT03164148 | Heart Rate Variability (HRV) in Pituitary Adenoma | unknown | N/A | 50 | Seoul St. Mary's HospitalOTHER | 1 | May 23, 2017 | clinicaltrials |
| NCT03161925 | Chinese Liver Cancer Clinical Survey(CLCS) | unknown | — | 5,000 | Beijing Insight Science & Technology Co. Ltd.OTHER | 0 | May 22, 2017 | clinicaltrials |
| NCT03149523 | Exhaustive Genetic and Immunological Characterization of Colon, Kidney and Liver Tumors(ExhauCRF) | unknown | — | 150 | European Georges Pompidou HospitalOTHER | 1 | May 17, 2017 | clinicaltrials |
| NCT02550613 | Evaluation of Treatment Response With Integrated MRI/PET in Patients With Hepatocellular Carcinoma | unknown | — | 100 | National Taiwan University HospitalOTHER | 1 | May 16, 2017 | clinicaltrials |
| NCT03114085 | Apatinib Combined With Capecitabine Compared With Apatinib Treat Advanced Hepatocellular Carcinoma | unknown | Phase 2 | 170 | First Affiliated Hospital of Guangxi Medical UniversityOTHER | 0 | May 15, 2017 | clinicaltrials |
| NCT03145285 | Activity of Abiraterone Acetate in the Management of Cushing's Syndrome in Patients With Adrenocortical Carcinoma(ABACUS) | unknown | Phase 2 | 10 | Azienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaOTHER | 1 | May 10, 2017 | clinicaltrials |
| NCT02330783 | Efficacy and Safety of Bevacizumab Plus Sorafenib for the Third-line Treatment in Metastatic Renal Cancer Patients | unknown | Phase 2 | 106 | Peking University Cancer Hospital & InstituteOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT00777244 | Efficacy of Adjuvant Mitotane Treatment (ADIUVO)(ADIUVO) | unknown | Phase 3 | 200 | University of Turin, ItalyOTHER | 7 | May 8, 2017 | clinicaltrials |
| NCT03138239 | The Potential Role of Ga-68-PSMA in Staging, Restaging and Monitoring Response in Primary Liver Cancer: Comparison With F-18-FDG | unknown | N/A | 16 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 0 | May 3, 2017 | clinicaltrials |
| NCT02420678 | Quality of Life in Patients With Hepatocellular Carcinoma | unknown | — | 300 | Asan Medical CenterOTHER | 1 | Apr 26, 2017 | clinicaltrials |
| NCT03130712 | A Study of GPC3-targeted T Cells by Intratumor Injection for Advanced HCC (GPC3-CART) | unknown | Phase 1 / Phase 2 | 10 | Shanghai GeneChem Co., Ltd.INDUSTRY | 1 | Apr 26, 2017 | clinicaltrials |
| NCT02030587 | Laparoscopic Adrenalectomy Versus Radiofrequency Ablation(LARFA) | unknown | N/A | 36 | Chinese University of Hong KongOTHER | 1 | Apr 25, 2017 | clinicaltrials |
| NCT02725996 | By Using Adoptive Transfer of Autologous NK Cells to Prevent Recurrence of Hepatocellular Carcinoma After Curative Therapy | unknown | Phase 2 | 140 | Southwest Hospital, ChinaOTHER | 1 | Apr 25, 2017 | clinicaltrials |
| NCT03124498 | A Study to Evaluate Autologous CIK Cells in Patients With Hepatocellular Carcinoma After TACE, PEIT or RFA | unknown | Phase 1 / Phase 2 | 55 | Chuan An Biotechnology Co., Ltd.INDUSTRY | 0 | Apr 21, 2017 | clinicaltrials |
| NCT03110068 | Preoperative Estimation of Microvascular Invasion in Hepatocellular Carcinoma | unknown | — | 370 | Ming KuangOTHER | 0 | Apr 12, 2017 | clinicaltrials |
| NCT00184015 | Bortezomib and Bevacizumab ("BB-mib-mab") in Patients With Advanced or Recurrent Renal Cell Cancer (RCC) | unknown | Phase 1 / Phase 2 | 50 | University of Southern CaliforniaOTHER | 1 | Apr 11, 2017 | clinicaltrials |
| NCT02838888 | Computer-assisted Detection of Colonic Polyps(KoloPol I) | unknown | — | 40 | Technical University of MunichOTHER | 1 | Apr 11, 2017 | clinicaltrials |
| NCT03094949 | Comparison Between Partial Nephrectomy and Ablation for Renal Tumor | unknown | N/A | 200 | Chinese PLA General HospitalOTHER | 1 | Mar 29, 2017 | clinicaltrials |
| NCT03090815 | Circulating Tumor DNA (ctDNA) as a Prognostic Tool in Patients With Advanced Lung Adenocarcinoma | unknown | — | 100 | The University of Hong KongOTHER | 1 | Mar 27, 2017 | clinicaltrials |
| NCT03084380 | Anti-GPC3 CAR-T for Treating GPC3-positive Advanced Hepatocellular Carcinoma (HCC) | unknown | Phase 1 / Phase 2 | 20 | Xinqiao Hospital of ChongqingOTHER | 1 | Mar 20, 2017 | clinicaltrials |
| NCT03082378 | Central Obesity and Hepatocellular Carcinoma | unknown | — | 200 | Chinese PLA General HospitalOTHER | 1 | Mar 17, 2017 | clinicaltrials |
| NCT01869088 | TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma | unknown | Phase 3 | 266 | Sun Yat-sen UniversityOTHER | 1 | Mar 16, 2017 | clinicaltrials |
| NCT03071705 | Metformin Plus TKI Use in Patients With Non-Small Cell Lung Carcinoma | unknown | N/A | 120 | Instituto Nacional de Cancerologia de MexicoOTHER | 1 | Mar 7, 2017 | clinicaltrials |
| NCT03069508 | Clemizole HCl for Subjects With Hepatocellular Carcinoma | unknown | Phase 2 | 12 | Eiger Group International, Inc.INDUSTRY | 1 | Mar 3, 2017 | clinicaltrials |
| NCT03066557 | Study of the Combination of TACE With Apatinib in Patients With Hepatocellular Carcinoma | unknown | N/A | 80 | Jiangsu Cancer Institute & HospitalOTHER | 0 | Feb 28, 2017 | clinicaltrials |
| NCT02282267 | Blood Detection of EGFR Mutation For Iressa Treatment(Benefit) | unknown | N/A | 188 | Peking University Cancer Hospital & InstituteOTHER | 1 | Feb 24, 2017 | clinicaltrials |
| NCT02936856 | Hepatic Arteriography in Liver Cancer Diagnosis and Staging Applications(RDSA) | unknown | N/A | 200 | Guangxi Medical UniversityOTHER | 1 | Feb 24, 2017 | clinicaltrials |
| NCT03063554 | EUS BD vs ERCP TP for Pancreatic Cancer(BILPAL) | unknown | N/A | 120 | Weill Medical College of Cornell UniversityOTHER | 1 | Feb 24, 2017 | clinicaltrials |
| NCT02956772 | Transcatheter Arterial Chemoembolization (TACE) in Combination With Arsenic Trioxide Versus TACE in the Treatment of Middle-advanced Primary Hepatocellular Carcinoma (HCC) Patients | unknown | Phase 2 | 190 | Hunan Provincial People's HospitalOTHER | 1 | Feb 23, 2017 | clinicaltrials |
| NCT02783261 | Prospective Post Y90 Liver Hypertrophy | unknown | — | 25 | Singapore General HospitalOTHER | 1 | Feb 14, 2017 | clinicaltrials |
| NCT03047525 | Study of DC-CTL Combined With CIK for Advanced Solid Tumor | unknown | Phase 1 / Phase 2 | 200 | Xiaoyi HuangOTHER | 1 | Feb 9, 2017 | clinicaltrials |
| NCT01665417 | Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma | unknown | Phase 4 | 100 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Feb 8, 2017 | clinicaltrials |
| NCT03046979 | Study of Apatinib in Advanced Hepatocellular Carcinoma(HCC)(HCC) | unknown | Phase 2 | 30 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Feb 8, 2017 | clinicaltrials |
| NCT02446795 | Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial(QUASAR) | unknown | Phase 1 / Phase 2 | 104 | Consorzio OncotechOTHER | 1 | Jan 18, 2017 | clinicaltrials |
| NCT03020342 | HBV-host cfDNA as Minimal Residual Tumor Marker for HBV-related HCC | unknown | — | 50 | National Taiwan University HospitalOTHER | 1 | Jan 13, 2017 | clinicaltrials |
| NCT01966133 | TACE as an Adjuvant Therapy After Hepatectomy for HCC | unknown | Phase 3 | 280 | Jia FanOTHER | 1 | Jan 9, 2017 | clinicaltrials |
| NCT02987699 | Phase II Study of HAIC Using Cisplatin,Leucovorin and 5-Fluorouracil | unknown | Phase 2 | 54 | Sun Yat-sen UniversityOTHER | 1 | Dec 28, 2016 | clinicaltrials |
| NCT02839954 | CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor | unknown | Phase 1 / Phase 2 | 10 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Dec 6, 2016 | clinicaltrials |
| NCT02587689 | Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor | unknown | Phase 1 / Phase 2 | 20 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Dec 5, 2016 | clinicaltrials |
| NCT01504997 | Phase II Study for Robot Assisted Distal Gastrectomy(RADGphaseII) | unknown | Phase 2 | 23 | Shizuoka Cancer CenterOTHER | 1 | Nov 29, 2016 | clinicaltrials |
| NCT02787447 | Radiotherapy Combined With Thymosin for Metastatic NSCLC Patients Who Showed Stable Disease After First Line TKI Therapy | unknown | Phase 2 | 46 | First People's Hospital of HangzhouOTHER | 1 | Nov 25, 2016 | clinicaltrials |
| NCT02057562 | Impact of Diverticular Disease on the Detection of Colon Adenomas(DECADE) | unknown | — | 1,000 | Technical University of MunichOTHER | 1 | Nov 21, 2016 | clinicaltrials |
Data updated 24 days agoSource updated Jun 22, 2017source: clinicaltrials